Answers are grounded in this paper and cite their sources.
OBJECTIVE: To evaluate the antiresorptive-cytokine effects of chondroitin sulfate on non-specific lower back pain in patients with knee osteoarthritis (OA). MATERIALS AND METHODS: - after 60 days with the assessment of blood parameters: transforming growth factor β1 (TFR β1), interleukin (IL)-1β and IL-6, beta-Crosslaps, bone matrix formation indicator P1NP (n-terminal propeptide procollagen type 1), and determination of the level of deoxypyridinoline (DPID) in the urine. RESULTS AND CONCLUSION: <0,001), which may indicate the presence of its own antiresorptive-cytokine effect in chondroitin sulfate.
No takes yet. Share an insight, caveat, or question.
Zolotovskaya et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: